4.6 Article

TSPO imaging-guided characterization of the immunosuppressive myeloid tumor microenvironment in patients with malignant glioma

期刊

NEURO-ONCOLOGY
卷 22, 期 7, 页码 1030-1043

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/neuonc/noaa023

关键词

TSPO; PET; glioma; imaging biomarker; tumor microenvironment; GAMs; TAMs; MDSCs; DPA-714

资金

  1. EU [278850]
  2. Horizon 2020 Programme [675417]
  3. Cells-in-Motion Cluster of Excellence [DFG EXC1003-CiM]
  4. IMI2-JU [831514]
  5. German Research Foundation [DFG: Fa474/5, SFB1009-Z02]
  6. Medical Faculty of the University of Munster
  7. Interdisciplinary Center for Clinical Research (IZKF core unit PIX), Munster, Germany

向作者/读者索取更多资源

Background. Tumor-associated microglia and macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs) are potent immunosuppressors in the glioma tumor microenvironment (TME).Their infiltration is associated with tumor grade, progression, and therapy resistance. Specific tools for image-guided analysis of spatiotemporal changes in the immunosuppressive myeloid tumor compartments are missing. We aimed (i) to evaluate the role of fluorodeoxyglucose (F-18)DPA-714* (translocator protein [TSPO]) PET-MRI in the assessment of the immunosuppressiveTME in glioma patients, and (ii) to cross-correlate imaging findings with in-depth immunophenotyping. Methods. To characterize the gliomaTME, a mixed collective of 9 glioma patients underwent [F-18]DPA-714-PET-MRI in addition to [F-18]fluoro-ethyl-tyrosine (FET)-PET-MRI. Image-guided biopsy samples were immunophenotyped by multiparametric flow cytometry and immunohistochemistry. In vitro autoradiography was performed for image validation and assessment of tracer binding specificity. Results. We found a strong relationship (r= 0.84, P= 0.009) between the [F-18]DPA-714 uptake and the number and activation level of glioma-associated myeloid cells (GAMs). TSPO expression was mainly restricted to human leukocyte antigen D related-positive (HLA-DR+) activated GAMs, particularly to tumor-infiltrating HLA-DR+ MDSCs andTAMs. [F-18] DPA-714-positive tissue volumes exceeded [F-18]FET-positive volumes and showed a differential spatial distribution. Conclusion. [F-18]DPA-714-PET may be used to non-invasively image the glioma-associated immunosuppressive THE in vivo. This imaging paradigm may also help to characterize the heterogeneity of the glioma TME with respect to the degree of myeloid cell infiltration at various disease stages. [F-18]DPA-714 may also facilitate the development of new image-guided therapies targeting the myeloid-derived TME.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据